Repligen (RGEN) Share-based Compensation (2010 - 2026)
Repligen's (RGEN) quarterly Share-based Compensation came in at $76.9 million in Q2 2026, up 818.21% year-over-year from $8.4 million in Q2 2025, and down 7.57% quarter-over-quarter from $83.2 million in Q1 2026.
Analysis
Repligen (RGEN) Share-based Compensation (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Share-based Compensation for 17 consecutive years, with $76.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 818.21% year-over-year to $76.9 million in Q2 2026; TTM through Jun 2026 was $76.9 million, a 70.65% increase from a year earlier, with the FY2025 full-year figure at $63.7 million, up 12.74% from the prior year.
- Share-based Compensation was $76.9 million for Q2 2026 at Repligen, down from $83.2 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $83.2 million in Q1 2026 and troughed at $3.4 million in Q4 2022.
- A 5-year average of $17.3 million and a median of $8.2 million in 2025 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation sank 94.72% in 2022 and jumped 1043.96% in 2026, its largest moves.
- Over 5 years, Share-based Compensation stood at $3.4 million in 2022, then soared by 88.98% to $6.5 million in 2023, then retreated by 1.64% to $6.4 million in 2024, then grew by 25.55% to $8.0 million in 2025, then jumped by 863.18% to $76.9 million in 2026.
- The last three Share-based Compensation figures came in at $76.9 million (Q2 2026), $83.2 million (Q1 2026), and $8.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 82.00 Mn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 93.00 Mn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 2.00 Mn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 73.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 10.73 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 5.23 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 76.90 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 25.62 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.90 Mn |
| Mar 31, 2026 | 83.20 Mn |
| Dec 31, 2025 | 7.98 Mn |
| Sep 30, 2025 | 8.97 Mn |
| Jun 30, 2025 | 8.38 Mn |
| Mar 31, 2025 | 7.27 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Jun 30, 2024 | 9.88 Mn |
| Mar 31, 2024 | 23.09 Mn |
| Dec 31, 2023 | 6.47 Mn |
| Sep 30, 2023 | 6.37 Mn |
| Jun 30, 2023 | 5.48 Mn |
| Mar 31, 2023 | 9.59 Mn |
| Dec 31, 2022 | 3.42 Mn |
| Sep 30, 2022 | 6.15 Mn |
| Jun 30, 2022 | 6.99 Mn |
| Mar 31, 2022 | 12.31 Mn |
| Dec 31, 2021 | 64.81 Mn |
| Sep 30, 2021 | 6.80 Mn |